HLA-G 14 bp deletion/insertion polymorphism in celiac disease

American Journal of Gastroenterology

Volumn 106, Issue 1, 2011, Pages 139-144

  Fabris, Annalisa ^a   Segat, Ludovica ^a,b   Catamo, Eulalia ^a   Morgutti, Marcello ^a   Vendramin, Anna ^a   Crovella, Sergio ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ2 ANTIGEN; HLA G ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; RNA STABILITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REFERENCE VALUES; RNA STABILITY; SEQUENCE DELETION; YOUNG ADULT;

EID: 78650996249     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.340     Document Type: Article

References (40)

1. Qiao SW, Sollid LM, Blumberg RS. Antigen presentation in celiac disease. Curr Opini Immunol 2009; 21: 111-7.
2. Green PH, Jabri B. Coeliac disease. Lancet 2003; 362: 383-91.
3. Mäki M, Mustalahti K, Kokkonen J et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348: 2517-24.
4. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transplant Immunol 2005; 14: 175-82.
5. Sollid LM, Th orsby E. HLA susceptibility genes in coeliac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993; 105: 910-22.
6. Mazzilli MC, Ferrante P, Mariani P et al. A study of Italian paediatric coeliac disease patients confirms that the primary HLA association is to the DQ ( 1*0501, 1*0201) heterodimer. Hum Immunol 1992; 33: 133-9.
7. Spurkland A, Sollid LM, Polanco I et al. HLA DR and DQ genotypes of celiac disease patients serologically typed to be non-DR3 and non-DR7/ DR5. Hum Immunol 1992; 35: 188-92.
8. Monsuur AJ, de Bakker PI, Alizadeh BZ et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005; 37: 1341-4.
9. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005; 3: 843-51.
10. Karell K, Holopainen P, Mustalahti K et al. Not all HLA DR3 DQ2 haplotypes confer equal susceptibility to coeliac disease: transmission analysis in families. Scand J Gastroenterol 2002; 37: 56-61.
11. Louka AS, Lie BA, Talseth B et al. Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics 2003; 55: 339-43.
12. Bolognesi E, Karell K, Percopo S et al. Additional factor in some HLA DR3/ DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 2003; 61: 308-16.
13. Le Maoult J, Rouas-Freiss N, Carosella ED., Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology. Autoimmun Rev., 2005, 4, 503-9.
14. Rouas-Freiss N, Gon ç alves RM, Menier C et al. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94: 11520-5.
15. Chaouat G, Led é e-Bataille N, Dubanchet S et al. Th 1/Th 2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the Th 1/Th 2 paradigm. Int Arach Allergy Immunol 2004; 134: 93-119.
16. Piccinni MP, Beloni L, Livi C et al. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998; 4: 1020-4.
17. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 2000; 48: 17-26.
18. Torres MI, L ó pez-Casado MA, Luque J et al. New advances in coeliac disease: serum and intestinal expression of HLA-G. Int Immunol 2006; 18: 713-8.
19. Torres MI, L ó pez Casado MA, Ríos A. New aspects in celiac disease. World J Gastroenterol 2007; 13: 1156-61.
20. Yie SM, Li L, Xiao R et al. A single base-pair mutation in the 3 -untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008; 14: 649-53.
21. Aikhionbare FO, Kumaresan K, Shamsa F et al. HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission. AIDS Res Ther 2006; 3: 28.
22. Hviid TV, Hylenius S, R ø rbye C et al. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003; 55: 63-79.
23. Rebmann V, van der Ven K, P ässler M et al. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001; 57: 15-21.
24. Rousseau P, Le Discorde M, Mouillot G et al. The 14 bp deletion-insertion polymorphism in the 3 UTR region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003; 64: 1005-10.
25. Walker-Smith JA, Guandalini S, Schmitz J et al. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-11.
26. Kaukinen K, Maki M, Partanen J et al. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci 2001; 46: 879-88.
27. Jarvinen TT, Collin P, Rasmussen M et al. Villous tip intraepithelial lymphocytes as markers of early-stage celiac disease. Scand J Gastroenterol 2004; 39: 428-33.
28. Monsuur AJ, de Bakker PI, Zhernakova A et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS ONE 2008; 3: e2270.
29. Koskinen L, Romano J, Kaukinen K et al. Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics 2009; 61: 247-56.
30. Brandao LC, Vatta S, Guimaraes R et al. Rapid genetic screening for major human leukocyte antigen risk haplotypes in patients with type 1 diabetes from Northeastern Brazil. Hum Immunol 2010; 71: 277-80.
31. Lin A, Yan WH, Xu HH et al. 14 bp deletion polymorphism in the HLA-G gene is a risk factor for idiopathic dilated cardiomyopathy in a Chinese Han population. Tissue Antigens 2007; 70: 427-31.
32. Solé X, Guinó E, Valls J et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22: 1928-9.
33. Megiorni F, Mora B, Bonamico M et al. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol 2008; 103: 997-1003.
34. Hviid TVF, Christiansen OB. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G ̄ possible implications for human reproduction and autoimmune disease. Hum Immunol 2005; 66: 688-99.
35. Margaritte-Jeannin P, Babron MC, Bourgey M et al. HLA-DQ relative risk for coeliac disease in European populations: a study of the European Genetic Cluster on Coeliac Disease. Tissue Antigens 2004; 63: 562-7.
36. Stepniak D, Koning F. Celiac disease-sandwiched between innate and adaptive immunity. Hum Immunol 2006; 67: 460-8.
37. Nilsen EM, Jahnsen FL, Lundin KE et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115: 551-63.
38. Wapenaar MC, van Belzen MJ, Fransen JH et al. The interferon gamma gene in celiac disease: augmented expression correlates with tissue damage but no evidence for genetic susceptibility. J Autoimmun 2004; 23: 183-90.
39. Mention JJ, Ben Ahmed M, Bègue B et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003; 125: 730-45.
40. Lefebvre S, Moreau P, Guiard V et al. Molecular mechanisms controlling constitutive and IFN- inducible HLA-G expression in various cell types. J Reprod Immunol 1999; 43: 213-24.